EGFR and central nervous system cancer: Intriguingly, suppressing P2 × 7R with an antagonist or shRNA promotes cell growth through the up-regulation of EGFR, p-EGFR, HIF-1α, and VEGF in glioma cells (Fang et al., 2013).